LENZ Therapeutics, Inc. - Common Stock
LENZ Therapeutics, Inc. - Common Stock
Share · US52635N1037 · LENZ (XNAS)
Overview
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
0
0
0
No Price
31.10.2025 23:09
Current Prices from LENZ Therapeutics, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
LENZ
USD
31.10.2025 23:09
29,76 USD
-0,70 USD
-2,30 %
Share Float & Liquidity
Free Float 85,55 %
Shares Float 24,4 M
Shares Outstanding 28,52 M
Company Profile for LENZ Therapeutics, Inc. - Common Stock Share
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
Get up to date insights from finAgent about LENZ Therapeutics, Inc. - Common Stock

Company Data

Name LENZ Therapeutics, Inc. - Common Stock
Company LENZ Therapeutics, Inc.
Symbol LENZ
Website https://www.lenz-tx.com
Primary Exchange XNAS NASDAQ
ISIN US52635N1037
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Evert B. Schimmelpennink
Market Capitalization 1 Mrd.
Country United States of America
Currency USD
Employees 0,0 T
Address 445 Marine View Avenue, 92014 Solana Beach
IPO Date 2024-03-22
Dividends from 'LENZ Therapeutics, Inc. - Common Stock'
Ex-Date Dividend per Share
22.03.2024 0,15 USD

ID Changes

Date From To
22.03.2024 GRPH LENZ

Ticker Symbols

Name Symbol
NASDAQ LENZ
More Shares
Investors who hold LENZ Therapeutics, Inc. - Common Stock also have the following shares in their portfolio:
DU PONT NEM 23/33
DU PONT NEM 23/33 Bond
ERSTE GR.BK. 22/36 MTN
ERSTE GR.BK. 22/36 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025